Spots Global Cancer Trial Database for Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
Official Title: Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
Study ID: NCT01349361
Interventions
Study Description
Brief Summary: Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Bispebjerg Hospital, Copenhagen NV, , Denmark
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
